scholarly journals Broad consent versus dynamic consent in biobank research: Is passive participation an ethical problem?

2013 ◽  
Vol 21 (9) ◽  
pp. 897-902 ◽  
Author(s):  
Kristin Solum Steinsbekk ◽  
Bjørn Kåre Myskja ◽  
Berge Solberg
2006 ◽  
Vol 7 (3) ◽  
pp. 266-269 ◽  
Author(s):  
Mats G Hansson ◽  
Joakim Dillner ◽  
Claus R Bartram ◽  
Joyce A Carlson ◽  
Gert Helgesson

2019 ◽  
Vol 46 (9) ◽  
pp. 627-628 ◽  
Author(s):  
Neil C Manson

In a recent article, I argued that Ploug and Holm’s ‘meta-consent’ proposal should be rejected for biobank governance. This was because, although meta-consent is permissible, it is both burdensome and ethically omissible. There is no ethical reason why funders should undertake the additional costs. Ploug and Holm have sought to respond to these arguments. Here, it is noted that not only do they fail to adequately refuse the case against meta-consent, they fail to even engage with the arguments, either misunderstanding them or ignoring them. In their response, Ploug and Holm unwittingly provide the basis of an even stronger case against meta-consent. They argue that broad consent has a built in tendency to expire, while also holding that broad consent should be one of the options available in meta-consent. Meta-consent thus ends up being more like dynamic consent, but, arguably, even more burdensome and costly.


2019 ◽  
Vol 45 (5) ◽  
pp. 295-297 ◽  
Author(s):  
Thomas Ploug ◽  
Soren Holm

In a recent article in the Journal of Medical Ethics, Neil Manson sets out to show that the meta-consent model of informed consent is not the solution to perennial debate on the ethics of biobank participation. In this response, we shall argue that (i) Manson’s considerations on the costs of a meta-consent model are incomplete and therefore misleading; (ii) his view that a model of broad consent passes a threshold of moral acceptability rests on an analogy that misconstrues how biobank research is actually conducted and (iii) a model of meta-consent is more in tune with the nature of biobank research and enables autonomous choice.


2019 ◽  
Vol 20 (1) ◽  
Author(s):  
Rasmus Bjerregaard Mikkelsen ◽  
Mickey Gjerris ◽  
Gunhild Waldemar ◽  
Peter Sandøe

Abstract Background As biobank research has become increasingly widespread within biomedical research, study-specific consent to each study, a model derived from research involving traditional interventions on human subjects, has for the sake of feasibility gradually given way to alternative consent models which do not require consent for every new study. Besides broad consent these models include tiered, dynamic, and meta-consent. However, critics have pointed out that it is normally not known at the time of enrolment in what ways samples deposited in a biobank may be used in future research and that, for a consent to be informed, exactly this kind of knowledge is required. Therefore, there is an ongoing debate about the ethical acceptability of going for less than study-specific consent. Main text In light of this debate we address the question of how to best protect participants against relevant risks and violations of autonomy. We apply the central aims of the informed consent process to the unique circumstances of biobank research where samples and data in many cases are stored for long periods of time and reused in subsequent studies. Thereby we are able to formulate a set of criteria focusing both on the risk of informational harm and the potential violation of participants’ values. We compare existing models of consent based on their ability to satisfy the criteria, and we find that the broad consent model offers the best level of protection for participants, although, it suffers from a few important deficiencies with regards to protection against participant value violations and long-term protection of autonomy, if it is applied without qualifications. For this reason, we propose modifications to the current broad consent model, in order to ensure that it provides protection of autonomy and participant values through strong ethical review and continuous communication. Conclusion We conclude that a modified form of broad consent is ethically superior in biobank research, not only because it is most feasible but primarily because it offers the best available protection against the hazards facing research subjects in this form of research.


2020 ◽  
Vol 46 (9) ◽  
pp. 629-631 ◽  
Author(s):  
Thomas Ploug ◽  
Søren Holm

In this response to Neil Manson’s latest intervention in our debate about the best consent model for biobank research we show, contra Manson that the ‘expiry problem’ that affects broad consent models because of changes over time in methods, purposes, types of data used and governance structures is a real and significant problem. We further show that our preferred implementation of meta consent as a national consent platform solves this problem and is not subject to the cost and burden objections that Manson raises.


2016 ◽  
Vol 59 (6-7) ◽  
pp. 295-309 ◽  
Author(s):  
D. Strech ◽  
S. Bein ◽  
M. Brumhard ◽  
W. Eisenmenger ◽  
C. Glinicke ◽  
...  

2016 ◽  
Vol 44 (1) ◽  
pp. 45-57 ◽  
Author(s):  
Sachin Chaturvedi ◽  
Krishna Ravi Srinivas ◽  
Vasantha Muthuswamy

Biobank-based research is not specifically addressed in Indian statutory law and therefore Indian Council for Medical Research guidelines are the primary regulators of biobank research in India. The guidelines allow for broad consent and for any level of identification of specimens. Although privacy is a fundamental right under the Indian Constitution, courts have limited this right when it conflicts with other rights or with the public interest. Furthermore, there is no established privacy test or actionable privacy right in the common law of India. In order to facilitate biobank-based research, both of these lacunae should be addressed by statutory law specifically addressing biobanking and more directly addressing the accompanying privacy concerns. A biobank-specific law should be written with international guidelines in mind, but harmonization with other laws should not be attempted until after India has created a law addressing biobank research within the unique legal and cultural environment of India.


Sign in / Sign up

Export Citation Format

Share Document